PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Nanobioengineering Group, Institute for Bioengineering of Catalonia (IBEC) Barcelona Institute of Science and Technology (BIST), 12 Baldiri Reixac 15-21, Barcelona, 08028, Spain.\', \'Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Monforte de Lemos 3-5, Pabellón 11, 28029, Madrid, Spain; Nanobioengineering Group, Institute for Bioengineering of Catalonia (IBEC) Barcelona Institute of Science and Technology (BIST), 12 Baldiri Reixac 15-21, Barcelona, 08028, Spain; Department of Electronics and Biomedical Engineering, Universitat de Barcelona, Martí I Franquès 1, 08028, Barcelona, Spain. Electronic address: mmir@ibecbarcelona.eu.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0039-9140(20)31189-910.1016/j.talanta.2020.121898
?:doi
?:hasPublicationType
?:journal
  • Talanta
is ?:pmid of
?:pmid
?:pmid
  • 33592692
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.186
?:rankingScore_hIndex
  • 141
?:title
  • Commercialized diagnostic technologies to combat SARS-CoV2: Advantages and disadvantages.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33592692>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33592692>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all